QBFM
MED icon

QS Batterymarch Financial Management’s Medifast MED Stock Holding History

QS Batterymarch Financial Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,300
Closed -$184K – 1004
2014
Q1 		$184K Hold
6,300
– – ﹤0.01% 902
2013
Q4 		$165K Hold
6,300
– – ﹤0.01% 918
2013
Q3 		$170K Hold
6,300
– – ﹤0.01% 893
2013
Q2 		$163K Buy
+6,300
New +$165K ﹤0.01% 911

Other funds holding MED

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
GGPE
Golden Gate Private Equity San Francisco, California $241M AUM 13.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

QS Batterymarch Financial Management's MED Position: Q2 2014 in Review

QS Batterymarch Financial Management sold out of Medifast (MED) in Q2 2014, closing a stake of 6,300 shares — an estimated $184K sold.

QS Batterymarch Financial Management first reported a position in MED in Q2 2013 and held it in 4 quarters. The position peaked at $184K in Q1 2014. 132 funds tracked by Wall St. Rank hold MED as of Q2 2014.

  • QS Batterymarch Financial Management reported no remaining Medifast position as of Q2 2014 after selling out during the quarter.
  • QS Batterymarch Financial Management sold 6,300 Medifast shares in Q2 2014, an estimated $184K.
  • QS Batterymarch Financial Management first reported a position in Medifast in Q2 2013 and held it in 4 quarters.
  • QS Batterymarch Financial Management's Medifast position peaked at $184K in Q1 2014.
  • 132 funds tracked by Wall St. Rank held Medifast as of Q2 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q2 2014, filed 14 Aug 2014.